191 related articles for article (PubMed ID: 36793734)
1. Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia.
Chen L; Ge M; Huo J; Ren X; Shao Y; Li X; Huang J; Wang M; Nie N; Zhang J; Peng J; Zheng Y
Front Immunol; 2023; 14():1056381. PubMed ID: 36793734
[TBL] [Abstract][Full Text] [Related]
2. HLA Class I Allele Loss and Bone Marrow Transplantation Outcomes in Immune Aplastic Anemia.
Zaimoku Y; Katagiri T; Nakagawa N; Imi T; Maruyama H; Takamatsu H; Ishiyama K; Yamazaki H; Miyamoto T; Nakao S
Transplant Cell Ther; 2024 Mar; 30(3):281.e1-281.e13. PubMed ID: 37972732
[TBL] [Abstract][Full Text] [Related]
3. Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients.
Song EY; Kang HJ; Shin HY; Ahn HS; Kim I; Yoon SS; Park S; Kim BK; Park MH
Hum Immunol; 2010 Jan; 71(1):88-92. PubMed ID: 19819281
[TBL] [Abstract][Full Text] [Related]
4. The polymorphisms of human leukocyte antigen loci may contribute to the susceptibility and severity of severe aplastic anemia in Chinese patients.
Wang M; Nie N; Feng S; Shi J; Ge M; Li X; Shao Y; Huang J; Zheng Y
Hum Immunol; 2014 Aug; 75(8):867-72. PubMed ID: 24979673
[TBL] [Abstract][Full Text] [Related]
5. Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities.
Olson TS; Frost BF; Duke JL; Dribus M; Xie HM; Prudowsky ZD; Furutani E; Gudera J; Shah YB; Ferriola D; Dinou A; Pagkrati I; Kim S; Xu Y; He M; Zheng S; Nijim S; Lin P; Xu C; Nakano TA; Oved JH; Carreno BM; Bolon YT; Gadalla SM; Marsh SG; Paczesny S; Lee SJ; Monos DS; Shimamura A; Bertuch AA; Gragert L; Spellman SR; Babushok DV
JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36219480
[TBL] [Abstract][Full Text] [Related]
6. Association of Human Leukocyte Antigen DRB1*15 and DRB1*15:01 Polymorphisms with Response to Immunosuppressive Therapy in Patients with Aplastic Anemia: A Meta-Analysis.
Liu S; Li Q; Zhang Y; Li Q; Ye B; Wu D; Wu L; Lu H; Ji C
PLoS One; 2016; 11(9):e0162382. PubMed ID: 27611583
[TBL] [Abstract][Full Text] [Related]
7. HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.
Zaimoku Y; Patel BA; Adams SD; Shalhoub R; Groarke EM; Lee AAC; Kajigaya S; Feng X; Rios OJ; Eager H; Alemu L; Quinones Raffo D; Wu CO; Flegel WA; Young NS
Blood; 2021 Dec; 138(26):2799-2809. PubMed ID: 34724566
[TBL] [Abstract][Full Text] [Related]
8. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics of clonal evolution after immunosuppressive therapy in children with severe/very severe aplastic anemia].
Zhang JL; Liu TF; Chang LX; Chen X; Ren YY; Sun CC; Liu C; An WB; Wan Y; Chen XJ; Yang WY; Wang SC; Guo Y; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jan; 19(1):27-33. PubMed ID: 28100318
[TBL] [Abstract][Full Text] [Related]
10. Association of aplastic anemia and FoxP3 gene polymorphisms in Koreans.
In JW; Lee N; Roh EY; Shin S; Park KU; Song EY
Hematology; 2017 Apr; 22(3):149-154. PubMed ID: 27702400
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.
Liu Q; Dong H; Li Y; Shen Y; Hong Y; Chen Y; Liu S; Wu X; Liu W; Hu H; Zhao Y; Lin S; Shen Y; Zhou Y; Ye B; Wu D
Lipids Health Dis; 2022 Oct; 21(1):93. PubMed ID: 36192750
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA class II (-DRB1,-DQB1,-DPB1) alleles and haplotypes on susceptibility to aplastic anemia in northern Chinese Han.
Qi J; Wang TJ; Li HX; Wu D; Du D; Wu JH; Shang LX; Chen L; Wang MN; Wang XF
Hum Immunol; 2020 Dec; 81(12):685-691. PubMed ID: 32693929
[TBL] [Abstract][Full Text] [Related]
13. [Clinical implications of combined measurement bone marrow T cells intracellular IFNgamma and HLA-DRB1*1501 measurement in predicting the response to immunosuppressive therapy for aplastic anemia].
Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF
Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):846-9. PubMed ID: 18218241
[TBL] [Abstract][Full Text] [Related]
14. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
Zhang X; Li Z; Geng W; Song B; Wan C
Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation for acquired aplastic anemia.
Georges GE; Storb R
Curr Opin Hematol; 2016 Nov; 23(6):495-500. PubMed ID: 27607445
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive therapy without hematopoietic growth factor exposure in pediatric acquired aplastic anemia.
Deyell RJ; Shereck EB; Milner RA; Schultz KR
Pediatr Hematol Oncol; 2011 Sep; 28(6):469-78. PubMed ID: 21707222
[TBL] [Abstract][Full Text] [Related]
17. Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia.
Betensky M; Babushok D; Roth JJ; Mason PJ; Biegel JA; Busse TM; Li Y; Lind C; Papazoglou A; Monos D; Podsakoff G; Bessler M; Olson TS
Cancer Genet; 2016; 209(1-2):1-10. PubMed ID: 26702937
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of detecting human leukocyte antigen class I allele-lacking leukocytes in aplastic anemia].
Hosokawa K; Nakao S
Rinsho Ketsueki; 2022; 63(8):899-905. PubMed ID: 36058861
[TBL] [Abstract][Full Text] [Related]
19. Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation.
Drexler B; Zurbriggen F; Diesch T; Viollier R; Halter JP; Heim D; Holbro A; Infanti L; Buser A; Gerull S; Medinger M; Tichelli A; Passweg JR
Ann Hematol; 2020 Nov; 99(11):2529-2538. PubMed ID: 32948913
[TBL] [Abstract][Full Text] [Related]
20. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.
Katagiri T; Sato-Otsubo A; Kashiwase K; Morishima S; Sato Y; Mori Y; Kato M; Sanada M; Morishima Y; Hosokawa K; Sasaki Y; Ohtake S; Ogawa S; Nakao S;
Blood; 2011 Dec; 118(25):6601-9. PubMed ID: 21963603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
